The West Lafayette biotech firm's stock traded as low as $1.41 last fall, following multiple setbacks and restructurings. But the stock had soared to $24 Thursday morning after news that it would be acquired by Novartis.
The Indianapolis-based office-supplies company had revenue near $38 million last year and is on target to hit $43 million this year. If the company hits its projections, revenue will have nearly tripled since 2013.
Business history is littered with colossally bad mergers that seemed brilliant at the time. So the insurer might benefit from avoiding the temptation to follow the current trend. Or it could get left in the dust.
Combining Indianapolis-based Finish Line Inc. and JD Sports Fashion from across the pond could create a firm within striding distance of the sports apparel industry's heavyweight, according to an analyst.